US Stock MarketDetailed Quotes

Edesa Biotech (EDSA)

Watchlist
  • 1.480
  • +0.040+2.78%
Close Jan 22 16:00 ET
12.33MMarket Cap-1.17P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Edesa Biotech (EDSA) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Sep 30, 2025
(Q4)Sep 30, 2025
(Q3)Jun 30, 2025
(Q2)Mar 31, 2025
(Q1)Dec 31, 2024
(FY)Sep 30, 2024
(Q4)Sep 30, 2024
(Q3)Jun 30, 2024
(Q2)Mar 31, 2024
(Q1)Dec 31, 2023
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
12.84%7.13M
129.85%2.22M
1.43%1.72M
-17.21%1.59M
-8.01%1.6M
-26.91%6.32M
-45.93%967.18K
-17.83%1.7M
-20.50%1.92M
-26.98%1.74M
Selling and administrative expenses
2.66%4.24M
38.22%1.24M
-6.81%964.68K
10.58%1.15M
-23.77%878.87K
-6.67%4.13M
-36.42%900.53K
-0.33%1.04M
9.63%1.04M
12.93%1.15M
-General and administrative expense
2.66%4.24M
38.22%1.24M
-6.81%964.68K
10.58%1.15M
-23.77%878.87K
-6.67%4.13M
-36.42%900.53K
-0.33%1.04M
9.63%1.04M
12.93%1.15M
Research and development costs
27.30%3.67M
1,079.92%1.23M
4.65%939.07K
-58.83%484.31K
44.77%1.02M
-39.89%2.88M
-89.11%103.87K
-12.51%897.31K
-19.33%1.18M
-48.10%704.46K
Other operating expenses
-12.26%-783.89K
-564.11%-247.15K
22.41%-183.28K
82.81%-52.27K
-149.26%-301.2K
-20.18%-698.28K
---37.22K
---236.23K
---304K
---120.83K
Operating profit
-12.84%-7.13M
-129.85%-2.22M
-1.43%-1.72M
17.21%-1.59M
8.01%-1.6M
26.91%-6.32M
45.93%-967.18K
17.83%-1.7M
20.50%-1.92M
26.98%-1.74M
Net non-operating interest income expense
-98.33%2.56K
-99.67%55
-98.26%572
-99.39%265
-97.27%1.67K
-47.04%153.5K
-77.08%16.49K
-60.31%32.85K
-49.61%43.19K
23.34%60.97K
Non-operating interest income
-98.33%2.56K
-99.67%55
-98.26%572
-99.39%265
-97.27%1.67K
-47.04%153.5K
-77.08%16.49K
-60.31%32.85K
-49.61%43.19K
23.34%60.97K
Other net income (expense)
-849.79%-59.61K
53.22%-5.32K
-510.91%-29.57K
-125.85%-3.3K
-659.21%-21.43K
71.13%-6.28K
-210.07%-11.36K
-40.28%-4.84K
246.76%12.75K
52.50%-2.82K
Gain on sale of security
-183.29%-59.61K
53.22%-5.32K
-510.91%-29.57K
-63.28%-3.3K
-659.21%-21.43K
3.22%-21.04K
-210.07%-11.36K
-40.28%-4.84K
76.77%-2.02K
52.50%-2.82K
Other non- operating income (expenses)
----
----
----
----
----
--14.77K
--0
----
--14.77K
----
Income before tax
-16.46%-7.18M
-131.63%-2.23M
-4.87%-1.75M
14.56%-1.59M
3.65%-1.62M
26.33%-6.17M
44.08%-962.05K
15.96%-1.67M
20.27%-1.86M
28.11%-1.68M
Income tax
0.00%800
0
0
0.00%800
0.00%800
0
0
0.00%800
Net income
-16.46%-7.19M
-131.63%-2.23M
-4.87%-1.75M
14.55%-1.59M
3.65%-1.62M
26.32%-6.17M
44.08%-962.05K
15.96%-1.67M
20.26%-1.86M
28.11%-1.68M
Net income continuous Operations
-16.46%-7.19M
-131.63%-2.23M
-4.87%-1.75M
14.55%-1.59M
3.65%-1.62M
26.32%-6.17M
44.08%-962.05K
15.96%-1.67M
20.26%-1.86M
28.11%-1.68M
Minority interest income
Net income attributable to the parent company
-16.46%-7.19M
-131.63%-2.23M
-4.87%-1.75M
14.55%-1.59M
3.65%-1.62M
26.32%-6.17M
44.08%-962.05K
15.96%-1.67M
20.26%-1.86M
28.11%-1.68M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-16.46%-7.19M
-131.63%-2.23M
-4.87%-1.75M
14.55%-1.59M
3.65%-1.62M
26.32%-6.17M
44.08%-962.05K
15.96%-1.67M
20.26%-1.86M
28.11%-1.68M
Basic earnings per share
34.20%-1.27
-10.34%-0.32
51.92%-0.25
48.28%-0.3
11.11%-0.48
34.13%-1.93
48.21%-0.29
23.53%-0.52
29.27%-0.58
39.33%-0.54
Diluted earnings per share
34.20%-1.27
-10.34%-0.32
51.92%-0.25
48.28%-0.3
11.11%-0.48
34.13%-1.93
48.21%-0.29
23.53%-0.52
29.27%-0.58
39.33%-0.54
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Sep 30, 2025(Q4)Sep 30, 2025(Q3)Jun 30, 2025(Q2)Mar 31, 2025(Q1)Dec 31, 2024(FY)Sep 30, 2024(Q4)Sep 30, 2024(Q3)Jun 30, 2024(Q2)Mar 31, 2024(Q1)Dec 31, 2023
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 12.84%7.13M129.85%2.22M1.43%1.72M-17.21%1.59M-8.01%1.6M-26.91%6.32M-45.93%967.18K-17.83%1.7M-20.50%1.92M-26.98%1.74M
Selling and administrative expenses 2.66%4.24M38.22%1.24M-6.81%964.68K10.58%1.15M-23.77%878.87K-6.67%4.13M-36.42%900.53K-0.33%1.04M9.63%1.04M12.93%1.15M
-General and administrative expense 2.66%4.24M38.22%1.24M-6.81%964.68K10.58%1.15M-23.77%878.87K-6.67%4.13M-36.42%900.53K-0.33%1.04M9.63%1.04M12.93%1.15M
Research and development costs 27.30%3.67M1,079.92%1.23M4.65%939.07K-58.83%484.31K44.77%1.02M-39.89%2.88M-89.11%103.87K-12.51%897.31K-19.33%1.18M-48.10%704.46K
Other operating expenses -12.26%-783.89K-564.11%-247.15K22.41%-183.28K82.81%-52.27K-149.26%-301.2K-20.18%-698.28K---37.22K---236.23K---304K---120.83K
Operating profit -12.84%-7.13M-129.85%-2.22M-1.43%-1.72M17.21%-1.59M8.01%-1.6M26.91%-6.32M45.93%-967.18K17.83%-1.7M20.50%-1.92M26.98%-1.74M
Net non-operating interest income expense -98.33%2.56K-99.67%55-98.26%572-99.39%265-97.27%1.67K-47.04%153.5K-77.08%16.49K-60.31%32.85K-49.61%43.19K23.34%60.97K
Non-operating interest income -98.33%2.56K-99.67%55-98.26%572-99.39%265-97.27%1.67K-47.04%153.5K-77.08%16.49K-60.31%32.85K-49.61%43.19K23.34%60.97K
Other net income (expense) -849.79%-59.61K53.22%-5.32K-510.91%-29.57K-125.85%-3.3K-659.21%-21.43K71.13%-6.28K-210.07%-11.36K-40.28%-4.84K246.76%12.75K52.50%-2.82K
Gain on sale of security -183.29%-59.61K53.22%-5.32K-510.91%-29.57K-63.28%-3.3K-659.21%-21.43K3.22%-21.04K-210.07%-11.36K-40.28%-4.84K76.77%-2.02K52.50%-2.82K
Other non- operating income (expenses) ----------------------14.77K--0------14.77K----
Income before tax -16.46%-7.18M-131.63%-2.23M-4.87%-1.75M14.56%-1.59M3.65%-1.62M26.33%-6.17M44.08%-962.05K15.96%-1.67M20.27%-1.86M28.11%-1.68M
Income tax 0.00%800000.00%8000.00%800000.00%800
Net income -16.46%-7.19M-131.63%-2.23M-4.87%-1.75M14.55%-1.59M3.65%-1.62M26.32%-6.17M44.08%-962.05K15.96%-1.67M20.26%-1.86M28.11%-1.68M
Net income continuous Operations -16.46%-7.19M-131.63%-2.23M-4.87%-1.75M14.55%-1.59M3.65%-1.62M26.32%-6.17M44.08%-962.05K15.96%-1.67M20.26%-1.86M28.11%-1.68M
Minority interest income
Net income attributable to the parent company -16.46%-7.19M-131.63%-2.23M-4.87%-1.75M14.55%-1.59M3.65%-1.62M26.32%-6.17M44.08%-962.05K15.96%-1.67M20.26%-1.86M28.11%-1.68M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -16.46%-7.19M-131.63%-2.23M-4.87%-1.75M14.55%-1.59M3.65%-1.62M26.32%-6.17M44.08%-962.05K15.96%-1.67M20.26%-1.86M28.11%-1.68M
Basic earnings per share 34.20%-1.27-10.34%-0.3251.92%-0.2548.28%-0.311.11%-0.4834.13%-1.9348.21%-0.2923.53%-0.5229.27%-0.5839.33%-0.54
Diluted earnings per share 34.20%-1.27-10.34%-0.3251.92%-0.2548.28%-0.311.11%-0.4834.13%-1.9348.21%-0.2923.53%-0.5229.27%-0.5839.33%-0.54
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +4.65%
Sample Name
Sample Code
 +4.15%
Sample Name
Sample Code
 +2.94%
4
Clean Energy Fuels
CLNE
+2.70%
5
American Express
AXP
+2.34%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +24.00%
Sample Name
Sample Code
 +7.99%
Sample Name
Sample Code
 +7.44%
4
KE Holdings
BEKE
+5.08%
5
NIO Inc
NIO
+4.61%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -